Free Content Effects of tetracycline on the pharmacokinetics of halofantrine in healthy volunteers

Authors: Bassi P.U.1; Onyeji C.O.; Ukponmwan O.E.2

Source: British Journal of Clinical Pharmacology, Volume 58, Number 1, July 2004 , pp. 52-55(4)

Publisher: Blackwell Publishing

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Aims

To investigate the effect of tetracycline co-administration on the pharmacokinetics of halofantrine in healthy subjects. Methods

Eight healthy males were each given 500 mg single oral doses of halofantrine alone, or with tetracycline (500 mg 12 hourly for 7 days), in a crossover fashion. Blood samples collected at predetermined intervals were analyzed for halofantrine and its major metabolite, desbutylhalofantrine (HFM), using a validated HPLC method. Results

Co-administration of tetracycline and halofantrine resulted in a significant increase (P < 0.05) in the maximum plasma concentration (Cmax), total area under the concentration-time curve (AUC), and terminal elimination half-life (t1/2,z), compared with halofantrine alone. (Cmax 0.43 ± 0.14 vs 1.06 ± 0.44 µg ml-1 (95% CI on the difference 0.30, 0.95); AUC 32.0 ± 13.6 vs 63.7 ± 20.1 µg ml-1 h (95% CI 14.2, 49.1); t1/2,z: 90.8 ± 17.9 vs 157.4 ± 57.4 h (95% CI 21.7, 111.5)). Similarly, tetracycline caused a significant increase (P < 0.05) in the AUC and Cmax of HFM. Conclusions

Tetracycline co-administration significantly increases the plasma concentrations of halofantrine and its major metabolite.

Keywords: halofantrine; interaction; pharmacokinetics; tetracycline

Document Type: Research article

DOI: 10.1111/j.1365-2125.2004.02087.x

Affiliations: 1: Department of Clinical Pharmacology, College of Medicine, University of Maiduguri, Maiduguri, Nigeria., 2: Department of Physiological Sciences, College of Health Sciences, Obafemi Awolowo University, Ile-Ife, Nigeria

You have access to the full text article on a website external to Ingentaconnect.

Please click here to view this article on InterScience.

You may be required to register and activate access on InterScience before you can obtain the full text. If you have any queries please contact onlinehelp@oxon.blackwellpublishing.com

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A